Junfei Jin
Impact in
- Molecular Biology top 5%
- Sphingolipid Metabolism and Signaling
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Extracellular vesicles in disease
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Sphingolipid Metabolism and Signaling 32
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Co-authors
- Lina Marie Obeid (9 shared papers)Yan Qin Huang (14 shared papers)Zhongyang Lu (11 shared papers)Jacek Bielawski (6 shared papers)Songqing He (17 shared papers)Cungui Mao (6 shared papers)Ruijuan Xu (6 shared papers)Zdzisław M. Szulc (6 shared papers)
- Journals
- Oncotarget (6 papers)The FASEB Journal (3 papers)Journal of Biological Chemistry (3 papers)Hepatology (2 papers)Journal of Lipid Research (2 papers)
- Partner nations
- ChinaUnited StatesIraq
In The Last Decade
Junfei Jin
103 papers receiving 3.5k citations
Junfei Jin's Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 1.7k
- Hepatology 196
- Periodontics 128
- Cancer Research 225
- Immunology 277
Countries citing papers authored by Junfei Jin
This map shows the geographic impact of Junfei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfei Jin more than expected).
Fields of papers citing papers by Junfei Jin
This network shows the impact of papers produced by Junfei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfei Jin. The network helps show where Junfei Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfei Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL3 and ALKBH5 oppositely regulate m 6 A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes Hit paper breakdown → | 2019 | 420 |
| 2 | 2019 | 187 | |
| 3 | 2006 | 130 | |
| 4 | 2019 | 100 | |
| 5 | 2009 | 96 | |
| 6 | 2007 | 89 | |
| 7 | 2013 | 88 | |
| 8 | 2005 | 87 | |
| 9 | 2019 | 82 | |
| 10 | 2014 | 79 | |
| 11 | 2012 | 73 | |
| 12 | 2008 | 71 | |
| 13 | 2020 | 61 | |
| 14 | 2011 | 59 | |
| 15 | 2015 | 58 | |
| 16 | 2012 | 55 | |
| 17 | 2010 | 54 | |
| 18 | 2014 | 54 | |
| 19 | 2016 | 54 | |
| 20 | 2013 | 53 |
About Junfei Jin
Junfei Jin is a scholar working on Molecular Biology, Hepatology, Immunology, Cancer Research and Periodontics, having authored 106 papers that have together received 3.6k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (32 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Immune Response and Inflammation (6 papers), Oral microbiology and periodontitis research (6 papers), Pancreatic function and diabetes (4 papers), Aldose Reductase and Taurine (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). The work is most often cited by research in Molecular Biology (1.7k citations), Hepatology (196 citations), Periodontics (128 citations), Cancer Research (225 citations) and Immunology (277 citations). Junfei Jin has collaborated with scholars based in China, United States and Iraq. Frequent co-authors include Lina Marie Obeid, Yan Qin Huang, Zhongyang Lu, Jacek Bielawski, Songqing He, Cungui Mao, Ruijuan Xu, Zdzisław M. Szulc, Yusuf Awni Hannun and Wei Ming Hu. Their work appears in journals such as Oncotarget, The FASEB Journal, Journal of Biological Chemistry, Hepatology and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.